Welcome to our dedicated page for Callan JMB news (Ticker: CJMB), a resource for investors and traders seeking the latest updates and insights on Callan JMB stock.
Callan JMB Inc. (NASDAQ: CJMB) is an integrative logistics company focused on highly regulated, temperature‑sensitive supply chains for healthcare, pharmaceuticals, and emergency preparedness. This news page aggregates company‑specific announcements, business updates, and regulatory disclosures so readers can follow how Callan JMB’s logistics, cold chain, and monitoring capabilities evolve over time.
Recent news highlights include strategic agreements and growth initiatives that shape the company’s role in integrated freight and logistics. Callan JMB has reported a strategic teaming agreement with Biostax Corp d/b/a Attune Biotech Inc., under which it will act as an independent third‑party overseer for manufacturing quality assurance, BARDA contract compliance, FDA audit readiness, federal reporting, and Strategic National Stockpile deployment coordination for Attune’s therapeutic pipeline. The company has also announced a strategic realignment toward cold‑chain infrastructure for GLP‑1 medications, including retrofitting its Texas cGMP facility for high‑capacity pharmaceutical‑grade refrigeration and positioning its cold‑chain technology for last‑mile fulfillment.
Other news items cover expansion into the food sampling sector, the launch of a subsidiary in India to establish a temperature‑controlled pharmaceutical warehouse, and upgrades to the proprietary Sentry Monitoring System to version 4.0, enabling web‑based access to temperature data and alarms from any device. Financial results releases provide context on revenue trends, contract extensions such as the long‑term City of Chicago emergency preparedness agreement, and capital markets activities including equity line arrangements.
Investors, analysts, and industry observers can use this page to review Callan JMB’s earnings releases, partnership announcements, technology upgrades, conference participation, and government contract updates, all in one place. Bookmark this feed to quickly access the latest CJMB news as reported in company press releases and SEC‑related communications.
Callan JMB (NASDAQ: CJMB), a healthcare and emergency management logistics company, reported its Q1 2025 financial results following its February IPO. The company raised $5.7 million through its IPO at $4.00 per share. Q1 2025 financial results showed revenue of $1.45 million, with a gross profit margin of 42.5%, but reported a net loss of $1.2 million due to increased SG&A expenses and declining emergency preparedness service demand.
Key developments include appointing Christopher Shields as SVP of Emergency Preparedness & Response, renewing contracts with Texas DSHS, securing a five-year contract with Oregon Health Authority, and launching a vaccine management lease program. The company is expanding into GLP-1 pharmaceutical transportation, specialized compounding pharmacy logistics, and premium food packaging services.
Callan JMB (NASDAQ: CJMB), a healthcare and emergency management logistics services provider, has announced its upcoming participation in the Aegis Capital Corp. Virtual Conference scheduled for May 21, 2025. The company's management team will deliver a presentation at 1:00 p.m. ET. Callan JMB specializes in fulfillment, storage, monitoring, and cold chain logistics services for the healthcare industry and emergency management agencies.
Callan JMB (NASDAQ: CJMB) has appointed Christopher Shields as Senior Vice President of Emergency Preparedness & Response/Government Affairs. Shields, former Assistant Commissioner of the Chicago Department of Public Health, brings over 14 years of experience managing the city's Emergency Preparedness and Bioterrorism program.
In his previous role, Shields managed the Tier 1 Medical Pharmacy operations, advanced vaccine inventory systems, and led critical functions including Continuity of Operations and Emergency Operations Planning. His extensive experience includes responding to major events such as 9/11, Hurricane Katrina, H1N1 Pandemic, and the COVID-19 crisis.
CEO Wayne Williams highlighted that Shields' appointment will help Callan JMB expand its emergency preparedness and response operations into new cities and states. The company currently provides integrative logistics services for healthcare industry and emergency management agencies, including fulfillment, storage, monitoring, and cold chain logistics services.
Callan JMB (NASDAQ: CJMB), a company specializing in integrative logistics for healthcare and emergency management agencies, has announced its participation in the upcoming LD Micro Invitational Conference in New York City.
The event will take place at the Westin Grand Central on April 9-10, 2025. The company's management team is scheduled to present on Thursday, April 10th at 3:30 p.m. ET in Track 3. The presentation will be accessible via webcast through the LD Micro platform.
Additionally, the management team will be available for one-on-one investor meetings during the conference, which can be arranged through LD Micro representatives or KCSA Strategic Communications.
Callan JMB (NASDAQ: CJMB), a logistics company specializing in healthcare and emergency management, reported its full year 2024 financial results. The company successfully completed its IPO on February 6, 2025, raising approximately $5.7 million at $4.00 per share.
Key financial metrics for 2024 include:
- Total revenue: $6.6 million ($3.8M from emergency response, $2.8M from specialty packaging)
- Gross profit: $2.6 million with 39.1% margin
- Operating loss: $2.3 million
- Net loss: $2.3 million
Notable achievements include extending arrangements with Texas DSHS, securing a five-year contract with Oregon Health Authority, launching a vaccine management lease program, and joining Complete Group Services. Revenue was impacted by reduced emergency preparedness services post-COVID and a temporary suspension of orders from one customer.
Callan JMB (NASDAQ: CJMB), a healthcare and emergency management logistics services provider, has announced its participation in two major investor conferences in March 2025.
The company will present at the Sidoti Spring Small-Cap Conference (March 19-20, virtual) with CEO Wayne Williams speaking on March 19th at 10:45 a.m. ET. Additionally, they will participate in the iAcccess Alpha Virtual Best Ideas Spring Investment Conference (March 25-26) with a presentation on March 25th at 10:30 a.m. ET.
Management will conduct one-on-one investor meetings during both conferences. Interested parties can schedule meetings through Sidoti or iAccess Alpha representatives, or by contacting KCSA Strategic Communications.
Callan JMB (NASDAQ: CJMB) has been requested by the Texas Department of Health and Human Services to be on standby for the recent measles outbreak response. The company holds a five-year contingency contract awarded in 2023 for receiving, storing, and distributing medical countermeasures for public health emergencies.
The company is proactively submitting a 30-day roster of 24/7 available personnel to handle distribution requests. This follows their successful track record from their first emergency response contract in 2018, which was activated during the COVID-19 and MPOX pandemic, where they managed the storage and distribution of over 2 million vaccines and therapeutics.
The current measles outbreak has claimed one life, and Callan JMB is preparing to support the state's emergency response with their expert staff, equipped facilities, and quality-controlled inventory management system.
Callan JMB (NASDAQ: CJMB) has launched an innovative lease program for immunization management infrastructure, targeting government agencies and private organizations. The program offers comprehensive vaccine management solutions without requiring substantial upfront equipment investments.
The lease package includes refrigerators, freezers, ultra-cold units, generators, computer equipment, and mobile clinic kits, all monitored by their proprietary Sentry system. This solution helps organizations avoid investing approximately $100,000 in equipment purchases.
The company's track record includes managing 2.27 million COVID-19 vaccine doses, 32.2 million testing supplies, and 113,401 COVID-19 therapeutics for Texas Department of State Health Services from April 2020 through January 2024. Callan JMB operates vaccine management centers in Texas, Oregon, and Illinois.
Callan JMB (NASDAQ: CJMB) announced successful immunization administration across 44 Tennessee counties through its partnership with Health Hero Tennessee. Since early 2023, the company has provided logistics support, specialized equipment, and regulatory compliance oversight for voluntary vaccination clinics at schools and community events.
The program focuses on underprivileged communities, offering free immunizations to uninsured individuals with parental consent. Callan JMB installed cold storage units, computer equipment, and its Sentry temperature monitoring system, providing real-time monitoring and backup generators. The facility mirrors similar operations in Oregon, Chicago, and Texas.
The company's model, inspired by its Texas backup facility for emergency medical supply storage, can be adapted for other state and local governments and healthcare organizations establishing community response centers or rural emergency medical response units.